C. James Hastie

6.3k citations

37 papers · 4.2k indexed · 1 hit paper · h-index 26

Molecular Biology top 2%
Cell Biology top 2%
Oncology top 5%
Cellular and Molecular Neuroscience top 5%
Immunology top 10%

Co-authors: Hilary McLauchlan Philip Cohen J. Simon C. Arthur Dario R. Alessi Jenny Bain Natalia Shpiro Matt Elliott Iva Klevernic
Topics: Microtubule and mitosis dynamics (11 papers)Ubiquitin and proteasome pathways (10 papers)Cancer-related Molecular Pathways (5 papers)
Cited by: Molecular Biology Cell Biology Aging
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Cell Biology
Partner nations: United Kingdom United States Spain

In The Last Decade

C. James Hastie

37 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The selectivity of protein kinase inhibitors: a further update

2007 2.1k citations C. James Hastie, Hilary McLauchlan et al. profile →

Peers

Countries citing papers authored by C. James Hastie

Since Specialization

Citations

This map shows the geographic impact of C. James Hastie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. James Hastie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. James Hastie more than expected).

Fields of papers citing papers by C. James Hastie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. James Hastie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. James Hastie. The network helps show where C. James Hastie may publish in the future.

Co-authorship network of co-authors of C. James Hastie

This figure shows the co-authorship network connecting the top 25 collaborators of C. James Hastie. A scholar is included among the top collaborators of C. James Hastie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. James Hastie. C. James Hastie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemo-Phosphoproteomic Profiling with ATR Inhibitors Berzosertib and Gartisertib Uncovers New Biomarkers and DNA Damage Response Regulators 2024 ·Molecular & Cellular Proteomics ·(unknown),Florian Weiland,Sylvie M. Noordermeer,Thomas Carroll,Yuandi Gao,Jianming Wang,Houjiang Zhou,Frédéric Lamoliatte,Rachel Toth,Thomas Macartney,Fiona Brown,C. James Hastie,Constance Alabert,Haico van Attikum,Frank T. Zenke,(unknown),John Rouse	2
2	One for all—human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses 2023 ·Journal of Virology ·Alison Daniels,Sarah Fletcher,(unknown),Annika Kratzel,Rute Maria Pinto,(unknown),Nicky Craig,C. James Hastie,Paul Davies,Paul Digard,Volker Thiel,Christine Tait‐Burkard	4
3	Functional characterization of C21ORF2 association with the NEK1 kinase mutated in human in diseases 2023 ·Life Science Alliance ·(unknown),(unknown),Iván Muñoz,Thomas Carroll,(unknown),Meagan Munro,Paweł Lis,Sven M. Lange,Frédéric Lamoliatte,Thomas Macartney,Rachel Toth,Fiona Brown,C. James Hastie,Gislene Pereira,Daniel Durocher,John Rouse	11
4	Activity-based probe profiling of RNF12 E3 ubiquitin ligase function in Tonne-Kalscheuer syndrome 2022 ·Life Science Alliance ·Francisco Bustos,Sunil Mathur,(unknown),Rachel Toth,C. James Hastie,Satpal Virdee,Greg M. Findlay	5
5	Generation of a chemical genetic model for JAK3 2021 ·Scientific Reports ·Judit Reményi,Rangeetha J. Naik,Jinhua Wang,(unknown),(unknown),Quan-Ying Cai,Li Tan,Rachel Toth,Samantha Raggett,(unknown),Ryan Traynor,C. James Hastie,Nathanael S. Gray,J. Simon C. Arthur	8
6	High-throughput matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry–based deubiquitylating enzyme assay for drug discovery 2020 ·Nature Protocols ·Virginia De Cesare,Jennifer L. Moran,Ryan Traynor,Axel Knebel,Maria Stella Ritorto,Matthias Trost,Hilary McLauchlan,C. James Hastie,Paul Davies	30
7	The MALDI-TOF E2/E3 Ligase Assay as Universal Tool for Drug Discovery in the Ubiquitin Pathway 2018 ·Cell chemical biology ·Virginia De Cesare,Clare Johnson,(unknown),C. James Hastie,Axel Knebel,Matthias Trost	49
8	Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling 2017 ·Proceedings of the National Academy of Sciences ·Sam Strickson,Christoph H. Emmerich,Eddy T. H. Goh,Jiazhen Zhang,Ian R. Kelsall,Thomas Macartney,C. James Hastie,Axel Knebel,Mark Peggie,Francesco Marchesi,J. Simon C. Arthur,Philip Cohen	88
9	CUL-2LRR-1 and UBXN-3 drive replisome disassembly during DNA replication termination and mitosis 2017 ·Nature Cell Biology ·Romain Sonneville,Sara Priego Moreno,Axel Knebel,Clare Johnson,C. James Hastie,Anton Gartner,Agnieszka Gambus,Karim Labib	81
10	Identifying Inhibitors of Inflammation: A Novel High-Throughput MALDI-TOF Screening Assay for Salt-Inducible Kinases (SIKs) 2017 ·SLAS DISCOVERY ·Rachel E. Heap,Anthony G. Hope,(unknown),Kathleen M. S. E. Reyskens,Stuart P. McElroy,C. James Hastie,David W. Porter,J. Simon C. Arthur,David W. Gray,Matthias Trost	41
11	Evidence that glycogen synthase kinase‐3 isoforms have distinct substrate preference in the brain 2010 ·Journal of Neurochemistry ·Marc P. M. Soutar,Woo‐Yang Kim,Ritchie Williamson,Mark Peggie,C. James Hastie,Hilary McLauchlan,William D. Snider,Phillip R. Gordon‐Weeks,Calum Sutherland	104
12	Novel Procedure To Investigate the Effect of Phosphorylation on Protein Complex Formation in Vitro and in Cells 2008 ·Biochemistry ·(unknown),Marc P. M. Soutar,(unknown),Robert Gourlay,C. James Hastie,Hilary McLauchlan,Nicholas A. Morrice,Adam R. Cole,Calum Sutherland	12
13	Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR 2007 ·DNA repair ·Paul A. Jowsey,Nicholas A. Morrice,C. James Hastie,Hilary McLauchlan,Rachel Toth,John Rouse	58
14	Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226 2006 ·BMC Molecular Biology ·(unknown),Sébastien Perrier,Christopher Lipina,David K. Finlay,Hilary McLauchlan,C. James Hastie,(unknown),Calum Sutherland	28
15	Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in Vivo 2006 ·Journal of Biological Chemistry ·Adam R. Cole,Frédéric Causeret,(unknown),C. James Hastie,Hilary McLauchlan,Edward J. McManus,Félix Hernández,Britta J. Eickholt,Margareta Nikolić,Calum Sutherland	186
16	The Saccharomyces cerevisiae orthologue of the human protein phosphatase 4 core regulatory subunit R2 confers resistance to the anticancer drug cisplatin 2006 ·FEBS Journal ·C. James Hastie,(unknown),(unknown),Michael J. R. Stark,Patricia T.W. Cohen	27
17	Assay of protein kinases using radiolabeled ATP: a protocol 2006 ·Nature Protocols ·C. James Hastie,Hilary McLauchlan,Philip Cohen	207
18	Phosphorylation of microtubule‐associated protein tau by isoforms of c‐Jun N‐terminal kinase (JNK) 2004 ·Journal of Neurochemistry ·Hirotaka Yoshida,C. James Hastie,Hilary McLauchlan,Philip Cohen,Michel Goedert	149
19	Molecular Basis for the Substrate Specificity of NIMA-related Kinase-6 (NEK6) 2002 ·Journal of Biological Chemistry ·José M. Lizcano,Mária Deák,Nick Morrice,Agnieszka Kieloch,C. James Hastie,Liying Dong,Mike Schutkowski,Ulf Reimer,Dario R. Alessi	82
20	Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters 1998 ·FEBS Letters ·C. James Hastie,Patricia T.W. Cohen	87

About C. James Hastie

C. James Hastie is a scholar working on Cell Biology, Oncology and Molecular Biology, having authored 37 papers that have together received 4.2k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (11 papers), Ubiquitin and proteasome pathways (10 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Molecular Biology (3.0k citations), Cell Biology (650 citations) and Aging (47 citations). C. James Hastie has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Hilary McLauchlan, Philip Cohen, J. Simon C. Arthur, Dario R. Alessi, Jenny Bain, Natalia Shpiro, Matt Elliott, Iva Klevernic, Patricia T.W. Cohen and Mark Peggie. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact